NEW YORK, May 24, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired common stock of Avinger, Inc. (“Avinger”) (NASDAQ:AVGR) pursuant and/or traceable to the Company’s Stock Offering on or about January 30, 2015. To get more information go to:
http://www.zlk.com/pslra/avinger-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that the Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading statements and/or failed to disclose that: (1) Avinger did not have adequate sales and marketing personnel to increase sales of its lumivascular platform products and to commercialize Pantheris; (2) the Company already experienced problems with the robustness of its lumivascular platform devices, including Pantheris; (3) physicians and hospitals were requiring more extensive and comprehensive training and education on the benefits of Avinger’s products to convince them to adopt and implement its lumivascular platform products compared to competing products and procedures available in the market; (4) Avinger would not be able to achieve a rapid ramp rate for increased sales of its lumivascular platform; and (5) as a result, the Company was experiencing lower sales and revenues.
Avinger priced its IPO at $13 per share. Since the IPO, however, Avinger stock has fallen to a recent close of $0.36 per share on May 23, 2017.
If you suffered a loss in Avinger and would like to obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/avinger-inc?wire=3.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 



